<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://feeds.theheart.org/~d/styles/rss2full.xsl" type="text/xsl" media="screen"?><?xml-stylesheet href="http://feeds.theheart.org/~d/styles/itemcontent.css" type="text/css" media="screen"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel>
    <title>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</title>
    <link>http://blogs.theheart.org/topolog</link>
    <description>
      <![CDATA[Topolog: by Eric J. Topol editor in chief of theheart.org and Dean of Scripps School of Medicine, helps translate clinical research in cardiology to daily practice.]]>
    </description>
    <language>en-us</language>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.theheart.org/Topolog" type="application/rss+xml" /><item>
      <title>JUPITER: How will it change your practice?</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;!--  /* Font Definitions */  @font-face 	{font-family:"MS Mincho"; 	panose-1:2 2 6 9 4 2 5 8 3 4; 	mso-font-alt:"ＭＳ 明朝"; 	mso-font-charset:128; 	mso-generic-font-family:modern; 	mso-font-pitch:fixed; 	mso-font-signature:-1610612033 1757936891 16 0 131231 0;} @font-face 	{font-family:"\@MS Mincho"; 	panose-1:2 2 6 9 4 2 5 8 3 4; 	mso-font-charset:128; 	mso-generic-font-family:modern; 	mso-font-pitch:fixed; 	mso-font-signature:-1610612033 1757936891 16 0 131231 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-parent:""; 	margin:0in; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman"; 	mso-fareast-font-family:"MS Mincho";} span.EmailStyle15 	{mso-style-type:personal; 	mso-style-noshow:yes; 	mso-ansi-font-size:10.0pt; 	mso-bidi-font-size:10.0pt; 	font-family:Arial; 	mso-ascii-font-family:Arial; 	mso-hansi-font-family:Arial; 	mso-bidi-font-family:Arial; 	color:windowtext;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --&gt;&lt;p class="MsoNormal"&gt;&lt;span style="font-size: 10pt; font-family: Arial"&gt;How do you interpret this landmark trial? Will you do CRPs in all patients? Or will you stick to the current guidelines? Will the trial results change your use of statins? Which statins will you use?&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal"&gt;&amp;nbsp;&lt;/p&gt;&lt;p class="MsoNormal"&gt;See: &lt;/p&gt;&lt;p class="MsoNormal"&gt;&amp;nbsp;&lt;/p&gt;&lt;!--  /* Font Definitions */  @font-face 	{font-family:"MS Mincho"; 	panose-1:2 2 6 9 4 2 5 8 3 4; 	mso-font-alt:"ＭＳ 明朝"; 	mso-font-charset:128; 	mso-generic-font-family:modern; 	mso-font-pitch:fixed; 	mso-font-signature:-1610612033 1757936891 16 0 131231 0;} @font-face 	{font-family:"\@MS Mincho"; 	panose-1:2 2 6 9 4 2 5 8 3 4; 	mso-font-charset:128; 	mso-generic-font-family:modern; 	mso-font-pitch:fixed; 	mso-font-signature:-1610612033 1757936891 16 0 131231 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-parent:""; 	margin:0in; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman"; 	mso-fareast-font-family:"MS Mincho";} span.EmailStyle15 	{mso-style-type:personal; 	mso-style-noshow:yes; 	mso-ansi-font-size:10.0pt; 	mso-bidi-font-size:10.0pt; 	font-family:Arial; 	mso-ascii-font-family:Arial; 	mso-hansi-font-family:Arial; 	mso-bidi-font-family:Arial; 	color:windowtext;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --&gt;&lt;p class="MsoNormal"&gt;&lt;span style="font-size: 10pt; font-family: Arial"&gt;&lt;a href="http://www.theheart.org/article/917181.do" target="_blank" title="JUPITER hits New Orleans: Landmark study shows statins benefit healthy individuals with high CRP levels"&gt;JUPITER hits New Orleans: Landmark study shows statins benefit healthy individuals with high CRP levels&lt;/a&gt; &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p class="MsoNormal"&gt;&amp;nbsp;&lt;/p&gt;&lt;p class="MsoNormal"&gt;&amp;nbsp;&lt;/p&gt;&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/447737881" height="1" width="1"/&gt;</description>
      <pubDate>Sun, 09 Nov 2008 15:50:00 -0500</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/447737881/jupiter--how-will-it-change-your-practice-</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/11/9/jupiter--how-will-it-change-your-practice-</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/11/9/jupiter--how-will-it-change-your-practice-</feedburner:origLink></item>
    <item>
      <title>Pfizer, Prasugrel and New Cardiovascular Drugs</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;p&gt;This week Pfizer announced its plans to stop CV development; last week the FDA announced they still were not in a position to approve prasugrel. Where is CV drug development headed?&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;See:&lt;/p&gt;&lt;p&gt;&lt;a href="http://www.theheart.org/article/907831.do" target="_blank" title="FDA once again postpones decision on prasugrel "&gt;FDA once again postpones decision on prasugrel&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;a href="http://www.theheart.org/article/908435.do" target="_blank" title="Pfizer to drop development of drugs for hyperlipidemia, atherosclerosis, and heart failure "&gt;Pfizer to drop development of drugs for hyperlipidemia, atherosclerosis, and heart failure&lt;/a&gt; &lt;/p&gt;&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/409441462" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 02 Oct 2008 12:52:00 -0400</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/409441462/pfizer--prasugrel-and-new-cardiovascular-drugs</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/10/2/pfizer--prasugrel-and-new-cardiovascular-drugs</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/10/2/pfizer--prasugrel-and-new-cardiovascular-drugs</feedburner:origLink></item>
    <item>
      <title>Putting SYNTAX In Context</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>At ESC in Munich, Hot line results from SYNTAX and CARDIA were presented.....what does this mean for deciding about PCI vs CABG?&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/382814341" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 02 Sep 2008 12:48:00 -0400</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/382814341/putting-syntax-in-context</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/9/2/putting-syntax-in-context</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/9/2/putting-syntax-in-context</feedburner:origLink></item>
    <item>
      <title>Statin Induced Myopathy</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;p&gt;Discussion of an important discovery published in NEJM. What are your thoughts on the implications for clinical practice?&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;u&gt;See these articles:&lt;/u&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=pubmed&amp;amp;cmd=Search&amp;amp;TransSchema=title&amp;amp;term=nejm%5BJour%5D%20AND%202008%5Bpdat%5D%20AND%20statin%20induced%20myopathy" title="SLCO1B1 Variants and Statin-Induced Myopathy -- A Genomewide Study. "&gt;SLCO1B1 Variants and Statin-Induced Myopathy -- A Genomewide Study.&lt;/a&gt;&amp;nbsp;&lt;/li&gt;&lt;li&gt;&lt;a href="http://www.theheart.org/article/883787.do" title="Genetic variants associated with risk of statin-induced myopathy"&gt;Genetic variants associated with risk of statin-induced myopathy&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/350055668" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 29 Jul 2008 15:19:00 -0400</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/350055668/statin-induced-myopathy</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/7/29/statin-induced-myopathy</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/7/29/statin-induced-myopathy</feedburner:origLink></item>
    <item>
      <title>CT Angiography: What is the Proper Role and Place?</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;p&gt;&amp;nbsp;&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Related Articles:&amp;nbsp;&lt;/strong&gt;&lt;/p&gt;  &lt;ul&gt;&lt;li&gt; 	&lt;a href="http://www.theheart.org/article/879165.do" target="_blank" title="CT angiography may be overused due to profit &amp;quot;incentive&amp;quot;"&gt; &lt;em&gt; &lt;font face="Times New Roman" size="1"&gt; &lt;span style="font-size: 9pt; font-style: italic"&gt;New York Times&lt;/span&gt;&lt;/font&gt;&lt;/em&gt; CT angiography may be overused due to  profit &amp;quot;incentive&amp;quot; [HeartWire&amp;nbsp;&amp;gt;&amp;nbsp;MediaPulse]; July 01,  2008&lt;/a&gt; &lt;/li&gt;&lt;li&gt; &lt;a href="http://www.theheart.org/article/837199.do" target="_blank" title="CMS moves to halt Medicare reimbursement of CT angiography, except in clinical trial"&gt;CMS moves to halt Medicare reimbursement of CT  angiography, except in clinical trials . [HeartWire&amp;nbsp;&amp;gt;&amp;nbsp;News]; January 11,  2008&lt;/a&gt; &lt;/li&gt;&lt;li&gt; &lt;a href="http://www.theheart.org/article/871565.do" target="_blank" title="CTA in the ER can safely and effectively screen for  ACS"&gt; CTA in the ER can safely and effectively screen for  ACS.&amp;nbsp; [HeartWire&amp;nbsp;&amp;gt;&amp;nbsp;Acute coronary syndromes]; June 02, 2008.&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/324588507" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 01 Jul 2008 12:35:00 -0400</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/324588507/ct-angiography--what-is-the-proper-role-and-place-</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/7/1/ct-angiography--what-is-the-proper-role-and-place-</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/7/1/ct-angiography--what-is-the-proper-role-and-place-</feedburner:origLink></item>
    <item>
      <title>Lessons From Tim Russert</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/313368082" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 16 Jun 2008 12:21:00 -0400</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/313368082/lessons-from-tim-russert</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/6/16/lessons-from-tim-russert</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/6/16/lessons-from-tim-russert</feedburner:origLink></item>
    <item>
      <title>POISED to Challenge Dogma: Peri-Op Beta Blockade</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;p&gt;&lt;span style="font-size: 10pt; font-family: Verdana"&gt;What will&amp;nbsp;be the impact on clinical practice of&amp;nbsp;the largest trial of peri-operative beta blockade including over 8,000 patients&amp;nbsp;at 190 centers in 23 countries?&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;span style="font-size: 10pt; font-family: Verdana"&gt;See:&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;span style="font-size: 10pt; font-family: Verdana"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=pubmed&amp;amp;cmd=Search&amp;amp;TransSchema=title&amp;amp;term=%22Lancet%22%5BJour%5D%20AND%20poise" target="_blank" title="Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial"&gt;&lt;font color="#800080"&gt;Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial&lt;/font&gt;&lt;/a&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="font-weight: normal; font-size: 10pt; color: #00415a; font-family: Verdana"&gt;&lt;a href="http://www.theheart.org/article/864785.do" target="_blank" title="POISE published, debate on perioperative beta blockers continues "&gt;&lt;font color="#800080"&gt;POISE published, debate on perioperative beta blockers continues&lt;/font&gt;&lt;/a&gt; &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;span class="articletitle"&gt;&lt;span style="font-size: 10pt; font-family: Verdana"&gt;&lt;a href="http://www.theheart.org/article/831165.do" target="_blank" title="POISE raises questions on perioperative use of beta blockers. But does it provide answers? "&gt;&lt;font color="#800080"&gt;POISE raises questions on perioperative use of beta blockers. But does it provide answers?&lt;/font&gt;&lt;/a&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="font-weight: normal; font-size: 10pt; color: #00415a; font-family: Verdana"&gt;&lt;a href="http://www.theheart.org/article/826435.do" target="_blank" title="POISEd to change the guidelines on perioperative use of beta blockers? "&gt;&lt;font color="#800080"&gt;POISEd to change the guidelines on perioperative use of beta blockers? &lt;/font&gt;&lt;/a&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/309290944" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 04 Jun 2008 11:36:00 -0400</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/309290944/poised-to-challenge-dogma--peri-op-beta-blockade</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/6/4/poised-to-challenge-dogma--peri-op-beta-blockade</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/6/4/poised-to-challenge-dogma--peri-op-beta-blockade</feedburner:origLink></item>
    <item>
      <title>Genetic Beta-Blockade</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;p&gt;See paper in Nature Medicine, April 20 2008 by Liggett SB et al&amp;nbsp; &lt;em&gt;A GRK polymorphism that inhibits beta-agrenergic receptor signaling is protective in heart failure&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Articles:&lt;/strong&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;A&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/18425130?ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank" title="A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure"&gt; GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure&lt;/a&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;a href="http://www.theheart.org/article/859047.do" target="_blank" title="&amp;quot;Genetic beta blockade&amp;quot; identified in some blacks "&gt;&amp;quot;Genetic beta blockade&amp;quot; identified in some blacks&lt;/a&gt; &lt;br /&gt;&amp;nbsp;&lt;/p&gt;&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/309290945" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 07 May 2008 17:23:00 -0400</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/309290945/genetic-beta-blockade</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/5/7/genetic-beta-blockade</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/5/7/genetic-beta-blockade</feedburner:origLink></item>
    <item>
      <title>From ACC 2008: Home Automated External Defibrillator Trial (HAT); how does government select what trials to fund?</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;span style="font-size: 10pt; color: navy"&gt;&lt;span style="font-size: 10pt; font-family: Verdana"&gt;&lt;font color="#000000"&gt;Findings from the &lt;strong&gt;&lt;span style="font-family: Verdana"&gt;Home Automated External Defibrillator Trial&lt;/span&gt;&lt;/strong&gt; (HAT) released at ACC show no advantage to owning a personal AED for post-MI patients in lives saved compared to the control arm. This raises several questions: When would an AED work? In the home setting, how would a family member detect malignant ventricular arrythmia? Given these difficulties, isn&amp;rsquo;t the negative outcome of the trial predictable? And given this, how does&amp;nbsp;government select what trials to fund?&lt;/font&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/309290946" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 04 Apr 2008 10:59:00 -0400</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/309290946/from-acc-2008--home-automated-external-defibrillator-trial--hat---how-does-government-select-what-trials-to-fund-</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/4/4/from-acc-2008--home-automated-external-defibrillator-trial--hat---how-does-government-select-what-trials-to-fund-</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/4/4/from-acc-2008--home-automated-external-defibrillator-trial--hat---how-does-government-select-what-trials-to-fund-</feedburner:origLink></item>
    <item>
      <title>Genomics and Prediction of Cardiovascular Events</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;p&gt;&lt;font face="OTNEJMQuadraat" size="2"&gt;&lt;span style="font-size: 10pt; font-family: Verdana"&gt;An interesting recent paper by Kathiresan and colleagues address the potential of 9 LDL and HDL Cholesterol genes to predict Death, MI and Stroke events. This topic is discussed and your input on this burgeoning&amp;nbsp;field is solicited.&amp;nbsp;&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: Verdana"&gt;&amp;nbsp;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;&lt;font face="OTNEJMQuadraat" size="2"&gt;&lt;span style="font-size: 10pt; font-family: Verdana"&gt;Kathiresan S, Melander O, Anevski D, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. &lt;em&gt;N Engl J Med&lt;/em&gt; 2008;358:1240-9.&lt;/span&gt; &lt;/font&gt;&lt;font face="OTNEJMQuadraat" size="2"&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/font&gt;&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/309290947" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 25 Mar 2008 17:38:00 -0400</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/309290947/genomics-and-prediction-of-cardiovascular-events</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/3/25/genomics-and-prediction-of-cardiovascular-events</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/3/25/genomics-and-prediction-of-cardiovascular-events</feedburner:origLink></item>
    <item>
      <title>Diabetes and Blood Sugar: The Art of De-Personalized Medicine</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>Two major trials--ACCORD and ADVANCE-have discrepant findings with respect to mortality excess in the aggressive Hemoglobin A1C arm. What is the explanation?&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/309290948" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 19 Feb 2008 13:46:00 -0500</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/309290948/diabetes-and-blood-sugar--the-art-of-de-personalized-medicine</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/2/19/diabetes-and-blood-sugar--the-art-of-de-personalized-medicine</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/2/19/diabetes-and-blood-sugar--the-art-of-de-personalized-medicine</feedburner:origLink></item>
    <item>
      <title>Temple of the LDL Cholesterol</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;p&gt;What a week in the field of lipids and CV medicine.....what's next?&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;span class="articleTitle"&gt;&lt;a href="http://www.theheart.org/article/837243.do" title="ENHANCE results yield disappointment for ezetimibe"&gt;ENHANCE results yield disappointment for ezetimibe&lt;/a&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://www.businessweek.com/magazine/content/08_04/b4068052092994.htm" target="_blank" title="Business Week: Do Cholesterol Drugs Do Any Good?"&gt;Business Week: Do Cholesterol Drugs Do Any Good?&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://www.americanheart.org/presenter.jhtml?identifier=3053094" title="Statement from the American Heart Association on ENHANCE study results"&gt;Statement from the American Heart Association on ENHANCE study results&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://jama.ama-assn.org/cgi/reprint/281/18/1718?maxtoshow=&amp;amp;HITS=10&amp;amp;hits=10&amp;amp;RESULTFORMAT=&amp;amp;fulltext=van+de+werf%2C+LDL&amp;amp;searchid=1&amp;amp;FIRSTINDEX=0&amp;amp;resourcetype=HWCIT" target="_blank" title="JAMA: Malondialdehyde-Modified LDL as a Marker of ACS"&gt;JAMA: Malondialdehyde-Modified LDL as a Marker of ACS&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/309290949" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 18 Jan 2008 09:44:00 -0500</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/309290949/temple-of-the-ldl-cholesterol</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2008/1/18/temple-of-the-ldl-cholesterol</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2008/1/18/temple-of-the-ldl-cholesterol</feedburner:origLink></item>
    <item>
      <title>Defibrillation Stagnation</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/309290950" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 20 Dec 2007 12:06:00 -0500</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/309290950/defibrillation-stagnation</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2007/12/20/defibrillation-stagnation</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2007/12/20/defibrillation-stagnation</feedburner:origLink></item>
    <item>
      <title>too many cardiology journals??</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>Circulation announced 6 more; JACC 2 more.....are they needed?&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/309290951" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 26 Nov 2007 13:21:00 -0500</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/309290951/too-many-cardiology-journals--</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2007/11/26/too-many-cardiology-journals--</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2007/11/26/too-many-cardiology-journals--</feedburner:origLink></item>
    <item>
      <title>TRITON</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>A Perspective on the Trial&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/309290952" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 05 Nov 2007 14:34:00 -0500</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/309290952/TRITON</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2007/11/5/TRITON</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2007/11/5/TRITON</feedburner:origLink></item>
    <item>
      <title>DLS vs DES</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/309290953" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 05 Nov 2007 14:33:00 -0500</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/309290953/DLS+vs+DES</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2007/11/5/DLS+vs+DES</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2007/11/5/DLS+vs+DES</feedburner:origLink></item>
    <item>
      <title>Welcome to AHA 2007</title>
      <category>Topolog from theheart.org: a blog by Dr.Topol for cardiologists</category>
      <description>&lt;img src="http://feeds.theheart.org/~r/Topolog/~4/309290954" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 02 Nov 2007 12:57:00 -0400</pubDate>
      <link>http://feeds.theheart.org/~r/Topolog/~3/309290954/Welcome</link>
      <guid isPermaLink="false">http://blogs.theheart.org/topolog/2007/11/2/Welcome</guid>
    <feedburner:origLink>http://blogs.theheart.org/topolog/2007/11/2/Welcome</feedburner:origLink></item>
  </channel>
</rss>
